by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview We are building a world-leading proprietary functional genomics and data intelligence platform enabling accelerated drug target development, higher trial success rates in oncology, and meaningful label expansions. Our core platform...
by Jeanine Verbeek | Feb 6, 2026
Startups Back to overview Omivera is a CRO that uses their proprietary CellEKT profiling technology to assess the safety and efficacy of the next generation of kinase targeting therapies. Omivera is a chemical proteomics company based in Leiden, dedicated to helping...
by Janeska de Jonge | Dec 2, 2024
Startups Back to overview RESPECTfarms pioneers the way of producing meat directly from animal stem cells, by providing farmers and food producers with a plug’n’play production system at their location. RESPECTfarms will build the world’s first...
by Janeska de Jonge | Dec 2, 2024
Startups Back to overview GlyCENA Advancing cell-based regenerative medicine applications by keeping them alive At GlyCENA we strive to advance cell-based regenerative medicine approaches and applications through the use of our patented nutritional nanoparticles....
by Janeska de Jonge | Nov 29, 2024
Startups Back to overview Predicts liver toxicity for the future drugs, compounds and chemicals helloR&D is a liver toxicity prediction company for novel drugs, compounds and chemicals. Based on our proprietary technology, the hepatocyte-like liver organoids...
